DGX Quest Diagnostics (DGX) Q2 FY26 earnings call
Quest Diagnostics delivered a strong second quarter, marked by robust organic revenue and adjusted EPS growth, leading to an upward revision of its full-year guidance. The company's strategic focus on physician, hospital, and consumer channels, alongside advanced diagnostics, is driving sustained demand. While operating margins faced headwinds from strategic investments and business mix, management expects full-year expansion and remains committed to operational excellence and innovation.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
DGX operating KPIs by quarter
| KPI | Mar 2026 Q1 FY26 | Sep 2026 Q3 FY26 | Change vs prior quarter |
|---|---|---|---|
| Patient service centers | 2,000There's many parts of the country where even though we have 2,000 patient service centers to conduct blood draws and urine collections, there's parts of the country where we simply don't have some of the coverage, and that includes areas in the upper Midwest, the Great Plains.Source: earnings call transcript | 2,000The panel also includes biometric measurements such as blood pressure and weight at the same time blood is drawn at one of our 2,000 patient service centers.Source: earnings call transcript | 0% |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.